| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |